XML 34 R28.htm IDEA: XBRL DOCUMENT v3.25.3
Equity Method Investment (Tables)
 9 Months Ended
Sep. 30, 2025
Equity Method Investments and Joint Ventures [Abstract]  
Schedule Of Equity Method Investments Our loss from our investment in Gannet BioChem for the three and nine months ended September 30, 2025 is as follows (in thousands):

 

 

Three Months Ended September 30, 2025

 

 

Nine Months Ended September 30, 2025

 

Claim on net assets of Gannet BioChem - beginning of period

 

$

5,371

 

 

$

12,218

 

Claim on net assets of Gannet BioChem - end of period

 

 

4,837

 

 

 

4,837

 

Change in claim on net assets of Gannet BioChem

 

$

(534

)

 

$

(7,381

)